Skip to main content

Mayne Pharma more than doubles FY losses

Mayne Pharma has more than doubled its full-year losses after the pharmaceutical company incurred a charge of $351.7 million due to the struggling US generic drug market.

from Breaking News | Daily Telegraph https://ift.tt/2Z5mVBk

Comments

Popular posts from this blog

Russian Drone Strike on Chernobyl Hasn’t Led to Rise in Radiation Levels

By Kim Barker from NYT World https://ift.tt/XZQikS1

Love Clothes? We Want to Hear About Your Favorite Stores.

By Kellina Moore from NYT Style https://ift.tt/4mtQDYs

20 Killed in Israeli Strikes as Israel and Hamas Trade Blame Over Truce

By Aaron Boxerman and Saher Alghorra from NYT World https://ift.tt/OzFTSBp